A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
Clinical trial NCT01243671 · COMPLETED
Trial details
- NCT number
- NCT01243671
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.